Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Induced Blood-Stage Malaria in Healthy Adults
NCT06607003Phase 1Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Incidence and severity of local and systemic adverse events (AEs) or serious adverse events (SAEs). Started Nov 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06607003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06607003.